Recalled Diabetic Syringes With Wrong Label Pose Risk Of Insulin Overdose
November 6, 2008 5:30 p.m. EST
Topics: HealthRockville, MD (AHN) - The U.S. Food and Drug Administration (FDA) has issued an alert that 471,000 mislabeled syringes for diabetics being recalled from Wal-Mart and Sam's Clubs stores pose risk of insulin overdose.

The agency warned patients and health care professionals not to use disposable 31-gauge, 1cc ReliOn syringes with Lot Number 813900 as its manufacturer, Tyco Healthcare Group LP (Covidien), recalled the product on Oct. 9, 2008 and Wal-Mart notified buyers to return them in exchange for replacements. The said syringes were sold at Wal-Mart and Sam's Clubs stores from Aug. 1, 2008 to Oct. 8, 2008.
The syringes being recalled are for use with U-40 insulin but were packed in boxes of syringes for use with U-100 insulin.
The FDA said using the wrong syringes could possibly give diabetics 2.5 times the intended insulin dose, which may lead to hypoglycemia, serious health consequences, and even death.

Email